drugset / Trial / NCT00690404

AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers

NCT00690404

Phase 1 Completed 20 enrolled AstraZeneca
RandomizedCrossoverOpen-label

Summary

A open label two way crossover formulation and food effect study in healthy volunteers to assess the pharmacokinetics of a single dose of AZD2066 new oral solid formulation and an oral solution

Timeline

Start
2008-04
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2066 Small molecule Oral

Indications

No indication recorded.